The global Protein Therapeutics market was valued at $191.4 billion in 2020 and is projected to reach $332.3 billion by 2028, growing at a CAGR of 6.98% from 2021 to 2028. This growth is driven by various macro and microeconomic factors, including the increased development of plasma-derived therapies, which significantly contributes to the expansion of the Protein Therapeutics market.
The latest research report by Evolve Business Intelligence explores the various factors influencing the global market. It includes an analysis of the current market size, forecasts for key segments and regions, and the driving forces behind market growth. The report examines the potential impacts of key trends on business strategies and provides a SWOT analysis of critical sectors for each major competitor and customer group. This valuable data highlights the conglomerates likely to impact the industry, crucial for any company planning to invest strategically over the next five years. These insights complement our initial quantitative study, aiding in new investments and strategic planning to mitigate threats in existing sectors.
Segments covered
By Product Type (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Others)
By Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Others)
Key players
Abbott Laboratories
Amgen Inc.
Baxter International Inc.
Eli Lilly and Company
Hoffmann-La Roche Ltd.
Johnson & Johnson, Merck & Co., Inc.
Novo Nordisk A/S, Pfizer Inc.
Sanofi
Biogen, Inc.
Genentech, Inc.
- Chapter 1. Executive Summary
- Chapter 2. Scope of The Study
- 2.1. Market Definition
- 2.2. Scope of The Study
- 2.2.1. Objectives of Report
- Chapter 3. Evolve BI Methodology
- Chapter 4. Market Insights and Trends
- 4.1. Supply/ Value Chain Analysis
- 4.2. Porter’s Five Forces Analysis
- 4.2.1. Threat of New Entrants
- 4.2.2. Bargaining Power of Buyers
- 4.2.3. Bargaining Power of Suppliers
- 4.2.4. Threat of Substitutes
- 4.2.5. Industry Rivalry
- 4.3. Impact of COVID-19 on Protein Therapeutics Market
- 4.3.1. Impact on Market Size
- 4.3.2. End User Trend, Preferences and Budget Impact
- 4.3.3. Regulatory Framework/Government Policies
- 4.3.4. Key Players Strategy to Tackle Negative Impact
- 4.3.5. Opportunity Window
- Chapter 5. Market Dynamics
- 5.1. Introduction
- 5.2. DRO Analysis
- 5.2.1. Drivers
- 5.2.2. Restraints
- 5.2.3. Opportunities
- Chapter 6. Global Protein Therapeutics Market, By Product Type
- 6.1. Introduction
- 6.2. Monoclonal Antibodies
- 6.3. Insulin
- 6.4. Fusion Protein
- 6.5. Erythropoietin
- 6.6. Interferon
- 6.7. Others
- Chapter 7. Global Protein Therapeutics Market, By Application
- 7.1. Introduction
- 7.2. Metabolic Disorders
- 7.3. Immunologic Disorders
- 7.4. Hematological Disorders
- 7.5. Cancer
- 7.6. Hormonal Disorders
- 7.7. Others
- Chapter 8. Global Protein Therapeutics Market, By Region
- 8.1. Introduction
- 8.2. North America
- 8.2.1. Introduction
- 8.2.2. Driving Factors, Opportunity Analyzed and Key Trends
- 8.2.3. Market Size and Forecast, By Country, 2020 - 2028
- 8.2.4. Market Size and Forecast, By Product Type, 2020 - 2028
- 8.2.5. Market Size and Forecast, By Application, 2020 – 2026
- 8.2.6. US
- 8.2.6.1. Introduction
- 8.2.6.2. Driving Factors, Opportunity Analyzed and Key Trends
- 8.2.6.3. Market Size and Forecast, By Product Type, 2020 - 2028
- 8.2.6.4. Market Size and Forecast, By Application, 2020 - 2028
- 8.2.7. Canada
- 8.2.7.1. Introduction
- 8.2.7.2. Driving Factors, Opportunity Analyzed and Key Trends
- 8.2.7.3. Market Size and Forecast, By Product Type, 2020 - 2028
- 8.2.7.4. Market Size and Forecast, By Application, 2020 - 2028
- 8.3. Europe
- 8.3.1. Introduction
- 8.3.2. Driving Factors, Opportunity Analyzed and Key Trends
- 8.3.3. Market Size and Forecast, By Country, 2020 - 2028
- 8.3.4. Market Size and Forecast, By Product Type, 2020 - 2028
- 8.3.5. Market Size and Forecast, By Application, 2020 – 2026
- 8.3.6. Germany
- 8.3.6.1. Introduction
- 8.3.6.2. Driving Factors, Opportunity Analyzed and Key Trends
- 8.3.6.3. Market Size and Forecast, By Product Type, 2020 - 2028
- 8.3.6.4. Market Size and Forecast, By Application, 2020 - 2028
- 8.3.7. France
- 8.3.7.1. Introduction
- 8.3.7.2. Driving Factors, Opportunity Analyzed and Key Trends
- 8.3.7.3. Market Size and Forecast, By Product Type, 2020 - 2028
- 8.3.7.4. Market Size and Forecast, By Application, 2020 - 2028
- 8.3.8. UK
- 8.3.8.1. Introduction
- 8.3.8.2. Driving Factors, Opportunity Analyzed and Key Trends
- 8.3.8.3. Market Size and Forecast, By Product Type, 2020 - 2028
- 8.3.8.4. Market Size and Forecast, By Application, 2020 - 2028
- 8.3.9. Italy
- 8.3.9.1. Introduction
- 8.3.9.2. Driving Factors, Opportunity Analyzed and Key Trends
- 8.3.9.3. Market Size and Forecast, By Product Type, 2020 - 2028
- 8.3.9.4. Market Size and Forecast, By Application, 2020 - 2028
- 8.3.10. Rest of Europe
- 8.3.10.1. Introduction
- 8.3.10.2. Driving Factors, Opportunity Analyzed and Key Trends
- 8.3.10.3. Market Size and Forecast, By Product Type, 2020 - 2028
- 8.3.10.4. Market Size and Forecast, By Application, 2020 - 2028
- 8.4. Asia-Pacific
- 8.4.1. Introduction
- 8.4.2. Driving Factors, Opportunity Analyzed and Key Trends
- 8.4.3. Market Size and Forecast, By Country, 2020 - 2028
- 8.4.4. Market Size and Forecast, By Product Type, 2020 - 2028
- 8.4.5. Market Size and Forecast, By Application, 2020 - 2028
- 8.4.6. China
- 8.4.6.1. Introduction
- 8.4.6.2. Driving Factors, Opportunity Analyzed and Key Trends
- 8.4.6.3. Market Size and Forecast, By Product Type, 2020 - 2028
- 8.4.6.4. Market Size and Forecast, By Application, 2020 - 2028
- 8.4.7. India
- 8.4.7.1. Introduction
- 8.4.7.2. Driving Factors, Opportunity Analyzed and Key Trends
- 8.4.7.3. Market Size and Forecast, By Product Type, 2020 - 2028
- 8.4.7.4. Market Size and Forecast, By Application, 2020 - 2028
- 8.4.8. Japan
- 8.4.8.1. Introduction
- 8.4.8.2. Driving Factors, Opportunity Analyzed and Key Trends
- 8.4.8.3. Market Size and Forecast, By Product Type, 2020 - 2028
- 8.4.8.4. Market Size and Forecast, By Application, 2020 - 2028
- 8.4.9. South Korea
- 8.4.9.1. Introduction
- 8.4.9.2. Driving Factors, Opportunity Analyzed and Key Trends
- 8.4.9.3. Market Size and Forecast, By Product Type, 2020 - 2028
- 8.4.9.4. Market Size and Forecast, By Application, 2020 - 2028
- 8.4.10. Rest of Asia-Pacific
- 8.4.10.1. Introduction
- 8.4.10.2. Driving Factors, Opportunity Analyzed and Key Trends
- 8.4.10.3. Market Size and Forecast, By Product Type, 2020 - 2028
- 8.4.10.4. Market Size and Forecast, By Application, 2020 - 2028
- 8.5. Rest of The World (RoW)
- 8.5.1. Introduction
- 8.5.2. Driving Factors, Opportunity Analyzed and Key Trends
- 8.5.3. Market Size and Forecast, By Product Type, 2020 - 2028
- 8.5.4. Market Size and Forecast, By Application, 2020 - 2028
- 8.5.5. Market Size and Forecast, By Region, 2020 - 2028
- 8.5.6. South America
- 8.5.6.1. Introduction
- 8.5.6.2. Driving Factors, Opportunity Analyzed and Key Trends
- 8.5.6.3. Market Size and Forecast, By Product Type, 2020 - 2028
- 8.5.6.4. Market Size and Forecast, By Application, 2020 - 2028
- 8.5.7. Middle East and Africa
- 8.5.7.1. Introduction
- 8.5.7.2. Driving Factors, Opportunity Analyzed and Key Trends
- 8.5.7.3. Market Size and Forecast, By Product Type, 2020 - 2028
- 8.5.7.4. Market Size and Forecast, By Application, 2020 - 2028
- Chapter 9. Competitive Landscape
- 9.1. Introduction
- 9.2. Vendor Share Analysis, 2020/Key Players Positioning, 2020
- Chapter 10. Company Profiles
- 10.1. Abbott Laboratories
- 10.1.1. Business Overview
- 10.1.2. Financial Analysis
- 10.1.3. Product Portfolio
- 10.1.4. Recent Development and Strategies Adopted
- 10.1.5. SWOT Analysis
- 10.2. Amgen Inc.
- 10.2.1. Business Overview
- 10.2.2. Financial Analysis
- 10.2.3. Product Portfolio
- 10.2.4. Recent Development and Strategies Adopted
- 10.2.5. SWOT Analysis
- 10.3. Baxter International Inc.
- 10.3.1. Business Overview
- 10.3.2. Financial Analysis
- 10.3.3. Product Portfolio
- 10.3.4. Recent Development and Strategies Adopted
- 10.3.5. SWOT Analysis
- 10.4. Eli Lilly and Company
- 10.4.1. Business Overview
- 10.4.2. Financial Analysis
- 10.4.3. Product Portfolio
- 10.4.4. Recent Development and Strategies Adopted
- 10.4.5. SWOT Analysis
- 10.5. F. Hoffmann-La Roche Ltd.
- 10.5.1. Business Overview
- 10.5.2. Financial Analysis
- 10.5.3. Product Portfolio
- 10.5.4. Recent Development and Strategies Adopted
- 10.5.5. SWOT Analysis
- 10.6. Johnson & Johnson, Merck & Co., Inc.
- 10.6.1. Business Overview
- 10.6.2. Financial Analysis
- 10.6.3. Product Portfolio
- 10.6.4. Recent Development and Strategies Adopted
- 10.6.5. SWOT Analysis
- 10.7. Novo Nordisk A/S, Pfizer Inc.
- 10.7.1. Business Overview
- 10.7.2. Financial Analysis
- 10.7.3. Product Portfolio
- 10.7.4. Recent Development and Strategies Adopted
- 10.7.5. SWOT Analysis
- 10.8. Sanofi
- 10.8.1. Business Overview
- 10.8.2. Financial Analysis
- 10.8.3. Product Portfolio
- 10.8.4. Recent Development and Strategies Adopted
- 10.8.5. SWOT Analysis
- 10.9. Biogen, Inc.
- 10.9.1. Business Overview
- 10.9.2. Financial Analysis
- 10.9.3. Product Portfolio
- 10.9.4. Recent Development and Strategies Adopted
- 10.9.5. SWOT Analysis
- 10.10. Genentech, Inc.
- 10.10.1. Business Overview
- 10.10.2. Financial Analysis
- 10.10.3. Product Portfolio
- 10.10.4. Recent Development and Strategies Adopted
- 10.10.5. SWOT Analysis
- Chapter 11. Key Takeaways
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook